Skip to main content
. 2012 Jun 18;7(6):e38778. doi: 10.1371/journal.pone.0038778

Figure 5. Efficacy of HepaRG-AMC-BAL treatment of rats with ALF.

Figure 5

Efficacy was demonstrated by a significantly increased survival time (P = 0.001) (A), the median clinical grading score for HE (B), increased time to reach clinical HE score 4 (P = 0.005) (C), lower blood ammonia levels (D), and lower plasma creatinine levels (E). Continuous lines indicate the control group and dotted lines indicate the experimental group. Values are expressed as median scores (B), or means ± standard deviations (D, E) (n = 5 to 6). Significance: * P<0.05 versus control group.